Literature DB >> 11510285

The relationship between dialysate protein loss and membrane transport status in peritoneal dialysis patients.

S Cooper1, E A Iliescu, A R Morton.   

Abstract

Peritoneal dialysis (PD) patients lose significant quantities of protein and albumin during the dialysis procedure. The losses are greater in high transporters. The aim of the present study was to investigate the relationship between peritoneal membrane transport characteristics and protein losses. We studied 33 PD patients [14 men, 19 women; mean age: 53.5 years (range: 21-80 years)]. Fourteen patients had diabetes, and 22 were on automated PD. Dialysis adequacy was good, with a mean Kt/V of 2.63 (range: 1.51-4.89). Patients underwent a standard peritoneal equilibration test (PET). In addition, dialysate albumin (Alb) and protein (Pro) were measured at 0, 1, 2, and 4 hours, after lack of interference from unspent dialysate was ensured. Of the 33 patients, 23 were high or high-average transporters [based on 4-hour dialysate-to-plasma ratio of creatinine (D/PCr > or = 0.65)]. Protein losses owing to PD ranged from 3.5 g/day to 13.2 g/day (median: 5.9 g/day), of which 1.9-7.14 g/day (median: 3.21 g/day) was albumin. The 4-hour D/PCr correlated with the 4-hour D/PAlb (r = 0.62, p < 0.01), and 4-hour D/PPro (r = 0.63, p < 0.01). This finding persisted after correction for volume, indicating that it was not simply a concentration effect. The 4-hour D/PAlb and 4-hour D/PPro also correlated with the 24-hour PD albumin and protein losses. These results suggest a strong association between D/PCr and D/P for proteins. This observation is consistent with the increased protein losses through PD in high transporters and may be related to the inferior outcomes in this group.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11510285

Source DB:  PubMed          Journal:  Adv Perit Dial        ISSN: 1197-8554


  6 in total

Review 1.  Managing Diabetes and Cardiovascular Risk in Chronic Kidney Disease Patients.

Authors:  Dragana Lovre; Sulay Shah; Aanu Sihota; Vivian A Fonseca
Journal:  Endocrinol Metab Clin North Am       Date:  2017-12-18       Impact factor: 4.741

2.  Successful treatment of icodextrin-single peritoneal dialysis for refractory nephrotic syndrome induced by idiopathic membranous nephropathy.

Authors:  Daisuke Takada; Akiko Mii; Seiichiro Higo; Yoshihiro Obara; Yuichi Kurabayashi; Norio Kurosawa; Shiro Miura; Hiroshi Kawachi; Akira Shimizu
Journal:  CEN Case Rep       Date:  2012-04-25

3.  Low-protein diet supplemented with keto acids is associated with suppression of small-solute peritoneal transport rate in peritoneal dialysis patients.

Authors:  Na Jiang; Jiaqi Qian; Aiwu Lin; Wei Fang; Weiming Zhang; Liou Cao; Qin Wang; Zhaohui Ni; Qiang Yao
Journal:  Int J Nephrol       Date:  2011-06-27

Review 4.  Glycated albumin is the preferred marker for assessing glycaemic control in advanced chronic kidney disease.

Authors:  Frederiek E Vos; John B Schollum; Robert J Walker
Journal:  NDT Plus       Date:  2011-12

5.  Peritoneal transport status and first episode of peritonitis: a large cohort study.

Authors:  Jing Hu; Hao Zhang; Bin Yi
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

6.  Baseline Peritoneal Membrane Transport Characteristics Are Associated with Peritonitis Risk in Incident Peritoneal Dialysis Patients.

Authors:  Yi-Hsin Chou; Yung-Tai Chen; Jinn-Yang Chen; Der-Cherng Tarng; Chih-Ching Lin; Szu-Yuan Li
Journal:  Membranes (Basel)       Date:  2022-02-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.